Saluda Medical
Macquarie Park, AustraliaWebsite
A global company developing the Evoke System, the first closed-loop spinal cord stimulation system for chronic pain management.
29open roles
Loading company information...
A global company developing the Evoke System, the first closed-loop spinal cord stimulation system for chronic pain management.
Company context
Saluda Medical prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Saluda Medical is a pioneering medical technology company dedicated to revolutionizing the field of neuromodulation. The company specializes in the development of closed-loop spinal cord stimulation systems designed to treat chronic intractable pain. By leveraging proprietary sensing technology, Saluda Medical's flagship Evoke System provides real-time, personalized therapy that automatically adjusts to the patient's neural response, marking a significant departure from traditional, fixed-output stimulation methods.
The company's mission is to revolutionize neuromodulation by eliminating the uncertainty in traditional pain management through precise, data-driven, and closed-loop sensing technology.
Founded
2013
Headquarters
Macquarie Park, Australia
Employees
200-500
Industry
Healthtech / Medtech
Opportunity to work on groundbreaking, life-changing medical technology.
High level of innovation and scientific rigor in product development.
High pressure associated with the medical device regulatory and clinical trial environment.
Challenges inherent in scaling a commercial-stage company across international markets.
Revenue
Pre-revenue to early commercial stage
Funding
Publicly traded (ASX: SLD); raised ~A$230.8 million in 2025 IPO
CEO
Dr. John Parker